loading page

A Case of Poorly Differentiated Hepatocellular Carcinoma, Lymphocyte-rich.
  • +11
  • Ginji Omori,
  • Takahiro Osuga,
  • Koji Miyanishi,
  • Kota Hamaguchi,
  • Shingo Tanaka,
  • Hiroyuki Ohnuma,
  • Kazuyuki Murase,
  • Kohichi Takada,
  • Minoru Nagayama,
  • Yasutoshi Kimura,
  • Ichiro Takemasa,
  • Yasuhiro Kikuchi,
  • Toshihiko Torigoe,
  • Junji Kato
Ginji Omori
Sapporo Medical University
Author Profile
Takahiro Osuga
Sapporo Medical University
Author Profile
Koji Miyanishi
Sapporo Medical University
Author Profile
Kota Hamaguchi
Sapporo Medical University
Author Profile
Shingo Tanaka
Sapporo Medical University
Author Profile
Hiroyuki Ohnuma
Sapporo Medical University
Author Profile
Kazuyuki Murase
Sapporo Medical University
Author Profile
Kohichi Takada
Sapporo Medical University
Author Profile
Minoru Nagayama
Sapporo Medical University
Author Profile
Yasutoshi Kimura
Sapporo Medical University
Author Profile
Ichiro Takemasa
Sapporo Medical University
Author Profile
Yasuhiro Kikuchi
Sapporo Medical University
Author Profile
Toshihiko Torigoe
Sapporo Medical University
Author Profile
Junji Kato
Sapporo Medical University
Author Profile

Abstract

A 70-year-old woman was diagnosed poorly differentiated hepatocellular carcinoma (HCC), lymphocyte rich. In this case, programmed cell death 1 expression was observed. Immune checkpoint inhibitor treatment may be effective in such cases, although there have been no reports of their use for poorly differentiated HCC, lymphocyte-rich.
24 May 2021Submitted to Clinical Case Reports
25 May 2021Submission Checks Completed
25 May 2021Assigned to Editor
04 Jun 2021Reviewer(s) Assigned
20 Jul 2021Review(s) Completed, Editorial Evaluation Pending
30 Jul 2021Editorial Decision: Revise Minor
12 Aug 20211st Revision Received
13 Aug 2021Submission Checks Completed
13 Aug 2021Assigned to Editor
13 Aug 2021Review(s) Completed, Editorial Evaluation Pending
15 Aug 2021Editorial Decision: Accept